MEK inhibition suppresses B regulatory cells and augments anti-tumor immunity.
Mark Yarchoan , Aditya A. Mohan , Lauren Dennison , Teena Vithayathil
PLOS ONE 14 ( 10)
5
2019
Response to crizotinib in ROS1 fusion–positive intrahepatic cholangiocarcinoma
Christopher D. Jakubowski , Aditya A. Mohan , Ihab R. Kamel , Mark Yarchoan
JCO Precision Oncology 4 ( 4) 825 -828
2020
Tumor and Systemic Immunomodulatory Effects of MEK Inhibition
Mark Yarchoan , Aditya A Mohan , Lauren Dennison
Current Oncology Reports 23 ( 2) 23
2021
Development, Practice Patterns, and Early Clinical Outcomes of a Multidisciplinary Liver Cancer Clinic.
Mark Yarchoan , Robert P Liddell , Nilofer S Azad , Christos Georgiades
Cancer Control 28 10732748211009945 -10732748211009945
2021
CD8+ T cells maintain killing of MHC-I-negative tumor cells through the NKG2D–NKG2DL axis
Emily C Lerner , Karolina I Woroniecka , Vincent M D’Anniballe , Daniel S Wilkinson
Nature Cancer 4 ( 9) 1258 -1272
26
2023
Targeting immunometabolism in glioblastoma
Aditya A Mohan , William H Tomaszewski , Aden P Haskell-Mendoza , Kelly M Hotchkiss
Frontiers in Oncology 11 696402 -696402
24
2021
Enhancing T cell chemotaxis and infiltration in glioblastoma
Kirit Singh , Kelly M Hotchkiss , Kisha K Patel , Daniel S Wilkinson
Cancers 13 ( 21) 5367 -5367
18
2021
For whom the T cells troll? Bispecific T-cell engagers in glioblastoma
Kirit Singh , Kelly M Hotchkiss , Aditya A Mohan , Jessica L Reedy
Journal for Immunotherapy of Cancer 9 ( 11)
11
2021
Systemic inhibition of PTPN22 augments anticancer immunity
Won Jin Ho , Sarah Croessmann , Jianping Lin , Zaw H Phyo
The Journal of Clinical Investigation 131 ( 17)
29
2021
Multicenter randomized phase II trial of atezolizumab with or without cobimetinib in biliary tract cancers
Mark Yarchoan , Leslie Cope , Amanda N Ruggieri , Robert A Anders
The Journal of Clinical Investigation 131 ( 24)
55
2021
Age and comorbidities predict COVID-19 outcome, regardless of innate immune response severity: A single institutional cohort study
Aditya A Mohan , Lyra B Olson , Ibtehaj A Naqvi , Sarah A Morrison
Critical Care Explorations 4 ( 12) e0799 -e0799
5
2022
Interdependencies of the neuronal, immune and tumor microenvironment in gliomas
Alexander Yuile , Joe Q Wei , Aditya A Mohan , Kelly M Hotchkiss
Cancers 15 ( 10) 2856 -2856
2
2023
Effects of B cell-activating factor on tumor immunity.
Mark Yarchoan , Won Jin Ho , Aditya Mohan , Yajas Shah
JCI insight 5 ( 10)
20
2020
NCOG-25. EFFICACY OF ANTICONVULSANT THERAPY IN GLIOMA PATIENTS
Ravi Medikonda , Kisha Patel , Laura Saleh , Siddhartha Srivastava
Neuro-oncology 22
2020
Smac mimetics synergize with immune checkpoint inhibitors to promote tumour immunity against glioblastoma
Shawn T. Beug , Caroline E. Beauregard , Cristin Healy , Tarun Sanda
Nature Communications 8 ( 1) 14278
80
2017
Publisher Correction: Smac mimetics synergize with immune checkpoint inhibitors to promote tumour immunity against glioblastoma.
Shawn T. Beug , Caroline E. Beauregard , Cristin Healy , Tarun Sanda
Nature Communications 9 ( 1) 16231
4
2018
Vascular patterning in human heterotopic ossification
Margaret Cocks , Aditya Mohan , Carolyn A. Meyers , Catherine Ding
Human Pathology 63 165 -170
11
2017
A novel MHC-independent mechanism of tumor cell killing by CD8+ T cells
Emily Lerner , Karolina Woroniecka , Vincent D’Anniballe , Daniel Wilkinson
bioRxiv 2023 -02
2023
Neoadjuvant cabozantinib and nivolumab convert locally advanced hepatocellular carcinoma into resectable disease with enhanced antitumor immunity
Won Jin Ho , Qingfeng Zhu , Jennifer Durham , Aleksandra Popovic
Nature Cancer 2 ( 9) 891 -903
31
2021
Neoadjuvant cabozantinib and nivolumab converts locally advanced HCC into resectable disease with enhanced antitumor immunity.
Won Jin Ho , Qingfeng Zhu , Jennifer Durham , Aleksandra Popovic
Nature cancer 2 ( 9) 891 -903
43
2021